BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome

    NEXT STORY
    T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections
    PREV STORY
    Athenex Announces Initiation of Phase I Clinical Study in China of KX2-361 Oral by Partner Guangzhou Xiangxue Pharmaceutical
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aptevo Therapeutics Provides Corporate and Pipeline Update

    author_avatar
    NASDAQ Market News

    Invitation: Terveystalo Half Year result audiocast and conference call on 17 August 2018

    Terveystalo Plc will publish its Half Year report for 2018 on Friday, 17 August ...

    author_avatar
    NASDAQ Market News

    Aduro Biotech to Present at the 38th Annual Cowen Healthcare Conference

    BERKELEY, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...

    author_avatar
    NASDAQ Market News